Altamira Therapeutics Ltd. CYTO
0.30 USD 0.00 (+0.00%)
At closeFeb 10, 2026, 4:00 PM EST
0.30 Day range 0.30
52-week range unavailable
- YTD
- 0.00%
- 1 year
- 0.00%
Revenue & Expenses
Latest period ending Dec 31, 2023 · select a line to chart its full history
Income statement
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| -5.92M | -18.01M | -6.87M | -5.50M | -7.26M | |
| -3.87M | -26.53M | -17.06M | -8.20M | -6.63M | |
| -7.88 | -582.58 | -515.11 | -505.40 | -45.60 |
Balance sheet
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| 617.41K | 15.39K | 984.19K | 11.26M | 1.38M | |
| 7.69M | 6.30M | 19.17M | 20.80M | 9.23M | |
| 1.24M | 14.62M | 6.13M | 4.03M | 3.19M | |
| 99.66K | 6.33M | 575.74K | 523.92K | 0 | |
| 6.46M | -8.31M | 13.04M | 16.77M | 6.04M |
Cash flow
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| -11.51M | -8.68M | -13.67M | -4.84M | -8.39M | |
| 1.44M | -2.14M | -3.51M | -2.31M | -3.00M | |
| 10.62M | 9.83M | 6.61M | 16.96M | 7.38M | |
| 555.42K | -993.07K | -10.56M | 9.80M | -4.02M |